SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-045313
Filing Date
2024-04-18
Accepted
2024-04-18 09:00:10
Documents
12
Period of Report
2024-04-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tbio-20240417.htm   iXBRL 8-K 46275
2 EX-99.1 PRESS RELEASE DATED APRIL 17, 2024 tbio-ex99_1.htm EX-99.1 21437
  Complete submission text file 0000950170-24-045313.txt   195674

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT tbio-20240417.xsd EX-101.SCH 26957
16 EXTRACTED XBRL INSTANCE DOCUMENT tbio-20240417_htm.xml XML 5103
Mailing Address 10431 WATERIDGE CIRCLE SUITE 150 SAN DIEGO CA 92121
Business Address 10431 WATERIDGE CIRCLE SUITE 150 SAN DIEGO CA 92121 858-228-4115
Telesis Bio Inc. (Filer) CIK: 0001850079 (see all company filings)

IRS No.: 451216839 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40497 | Film No.: 24852992
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)